CEIN
Viking Global Technologies, Inc.$0.0400 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $0.0400
Next earnings
Nov 10
in 14 days
Since first trade
+33.3%
from $0.0300 · Jul 17
30 days
+33.3%
from $0.0300
Range since listing
$0.0200–0.0400
0% from high · low Aug 24
Avg volume 20D
332.9K
shares / day
Short interest
309.5K
0.0%
Days to cover
1.0
at average volume
Filing reports
2
analyzed by SecBot
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 10, 2026
Price
Daily candles with volume.
No data for this timeframe.
Signal stack
Where each data set points today.
- Short sellersSTEADY
Short interest 0.0% to 309.5K shares. 1.0 days to cover.
- TrendUPTREND
32% above its 50-day average. New closing high $0.0400 on Oct 26.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 2, 2026 SEC
Viking Global Technologies (CEIN) amended its $1.2M convertible note with FK Venture LLC, extending the maturity to…
8-K — Impact 5/10
Sep 8, 2026 Event
Metformin Hydrochloride
WARNING: LACTIC ACIDOSIS Postmarketing cases of metformin-associated lactic acidosis have resulted i
Aug 6, 2026 Earnings calendar
Apr 13, 2026 SEC CEIN Q2 2026 Earnings Scheduled — 2026-08-06
Camber Energy provided an update on the continued validation, field deployment, and technical advancements of its…
8-K — Impact 5/10
Earnings setup
EstimatesNov 10
reports in 14 days
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Sep 30, 2026309,497
shares short
0.0%
vs prior settlement
1.0
days to cover
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Sep 8, 2026
FDA
Metformin Hydrochloride
WARNING: LACTIC ACIDOSIS Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant b
Aug 13, 2026
FDA
Abacavir
WARNING: HYPERSENSITIVITY REACTIONS Serious and sometimes fatal hypersensitivity reactions, with multiple organ involvement, have occurred with abacav
Aug 6, 2026
Earnings date
CEIN Q2 2026 Earnings Scheduled — 2026-08-06
Jul 29, 2026
FDA
Lamivudine
WARNING: EXACERBATIONS OF HEPATITIS B and RISK OF HIV-1 RESISTANCE IF LAMIVUDINE TABLETS (HBV) IS USED IN PATIENTS WITH UNRECOGNIZED OR UNTREATED HIV-
Jul 4, 2026
FDA
Abacavir
WARNING: HYPERSENSITIVITY REACTIONS Serious and sometimes fatal hypersensitivity reactions, with multiple organ involvement, have occured with abacavi
SecBot reports
2 filings · 1 bullish · 1 bearish- BEARISH 8-KOct 2, 2026
Viking Global Technologies (CEIN) amended its $1.2M convertible note with FK Venture LLC…
The combination of a maturity extension on an existing convertible note and a new short-term loan from insiders suggests the parent company and its subsidiary are struggling to secure conventional…
- BULLISH 8-KApr 13, 2026
Camber Energy provided an update on the continued validation, field deployment, and technical…
Monitor for future commercial agreements or partnerships with utilities, as successful validation could lead to revenue-generating opportunities.
All CEIN filing & press-release reports (2)
- 8-K reportOct 2, 2026
- 8-K reportApr 13, 2026